KFF: Costly GLP-1 Drugs are Rarely Covered for Weight Loss by Marketplace Plans
June 13, 2024
June 13, 2024
SAN FRANCISCO, California, June 13 (TNSres) -- KFF, an organization that says it focuses on health policy, issued the following news release:
* * *
For Drugs Used to Treat Diabetes, Plans Almost Always Require Prior Authorization or Other Utilization Management
* * *
Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis (https://www.healthsystemtracker.org/bri . . .
* * *
For Drugs Used to Treat Diabetes, Plans Almost Always Require Prior Authorization or Other Utilization Management
* * *
Affordable Care Act (ACA) Marketplace plans rarely cover GLP-1 drugs approved solely for obesity treatment, according to a new KFF analysis (https://www.healthsystemtracker.org/bri . . .